文献速递主动脉疾病

原生升主动脉直径>38 mm患者腔内弓部修复的结局观察

Outcomes after Endovascular Arch Repair in Patients with a Native Ascending Aorta Diameter Greater than 38 mm: An Observational Study in Two High Volume Centres.
PubMed 文献 · Eur J Vasc Endovasc Surg · 2026-01-17

两中心回顾性观察研究纳入25例原生升主动脉直径>38 mm并接受定制分支支架腔内弓部修复的患者,占同期228例的14%。技术成功率96%,但30天死亡率达40%,主要死亡原因包括逆行性A型夹层和心脏压塞。

要点

  • 升主动脉直径>38 mm者行腔内弓部修复技术可行,但30天死亡率高达40%。
  • 术后早期并发症包括卒中、脊髓缺血和逆行性A型夹层,多发生于术后第一周。
  • 应严格选择患者并在经验丰富的主动脉中心开展,条件允许时考虑开放手术。

核心结论

  • 定制分支支架腔内弓部修复用于原生升主动脉扩张(>38 mm)患者技术可行,但急诊比例高且早期并发症和死亡率显著。
  • 研究强调需谨慎选择患者、精细规划和在经验丰富的主动脉中心实施,条件允许时应考虑开放修复。

研究设计与样本

  • 两中心回顾性观察研究,纳入2018年7月至2025年4月连续接受定制弓部分支支架腔内修复且原生升主动脉直径>38 mm的患者25例(占同期228例的14%)。
  • 患者中位年龄68.9岁,68%为男性,平均升主动脉直径41.28±2.94 mm。

主要发现

  • 手术指征为胸主动脉瘤19例(76%)、主动脉夹层3例(12%)、穿透性溃疡3例(12%),9例(36%)在急诊条件下完成。
  • 技术成功率96%,术中1例死于逆行性A型夹层,术中未观察到卒中或I型、III型内漏。
  • 30天内大卒中8%(2例)、小卒中12%(3例),脊髓缺血和逆行性A型夹层各3例。
  • 30天死亡率为40%(择期24%,6例;急诊16%,4例),多数死亡发生在术后第一周。

关键数值与推荐

  • 平均近端oversizing为13%。
  • 主动脉相关死亡包括逆行性A型夹层3例和心脏压塞2例,另观察到心肌梗死2例。

临床怎么用

  • 对原生升主动脉直径>38 mm患者行腔内弓部修复需充分评估急诊需求与早期风险,在经验丰富的中心开展并做好开放手术备选。
  • 术前精细测量与规划(如oversizing控制)及术后第一周密切监测对降低早期死亡和并发症至关重要。

局限性

  • 原文未报告

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: This study aimed to evaluate early outcomes of endovascular aortic arch repair using custom made stent grafts in patients with a native ascending aortic diameter > 38 mm. METHODS: This two centre, retrospective observational study included all consecutive patients who underwent endovascular arch repair with custom made arch branched stent grafts for a native ascending aorta diameter > 38 mm. RESULTS: From July 2018 to April 2025, 228 patients were treated with an arch branch device; 25 of these patients (median age 68.9 years; 68% men) with a native ascending aorta diameter > 38 mm (mean 41.28 ± 2.94 mm) (14% of total cohort) underwent endovascular arch repair for thoracic aortic aneurysm (n = 19, 76%), aortic dissection (n = 3, 12%), or penetrating ulcer (n = 3, 12%). Nine procedures (36%) were performed under urgent conditions. The mean proximal oversizing was 13%. Technical success was achieved in 96%, with one intra-operative death caused by retrograde type A dissection. No intra-operative stroke or type I or III endoleak was observed. Within 30 days, major and minor strokes occurred in 8% (n = 2) and 12% (n = 3) of patients, respectively. Spinal cord ischaemia and retrograde type A dissection were each observed in three cases. The 30 day mortality rate was 40% (elective 24%, n = 6; urgent 16%, n = 4). Aortic related deaths included retrograde type A dissection (n = 3) and cardiac tamponade (n = 2). Myocardial infarctions (n = 2) were also observed. Additional deaths were attributed to stroke, pulmonary embolism, or unknown causes. Most deaths occurred within the first post-operative week. CONCLUSION: Endovascular arch repair using custom made branched endografts in patients with a dilated native ascending aorta (> 38 mm) is technically feasible but often performed in urgent settings and associated with substantial early morbidity and mortality. These findings underscore the importance of careful patient selection, meticulous planning, and performance in experienced aortic centres where open repair should be considered when feasible. Continued device optimisation is essential before wider clinical application.

来源:Eur J Vasc Endovasc Surg,查看原文。版权归原作者所有。

引用

  1. Wan Z, Jama K, Hasemaki N, et al. Outcomes after Endovascular Arch Repair in Patients with a Native Ascending Aorta Diameter Greater than 38 mm: An Observational Study in Two High Volume Centres. Eur J Vasc Endovasc Surg. 2026. PMID: 41554372. doi:10.1016/j.ejvs.2026.01.022

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。